# Differences in Endothelial Function Amongst Sitagliptin and Liraglutide Users

> **NCT01785043** · PHASE4 · COMPLETED · sponsor: **Anna Cruceta** · enrollment: 13 (actual)

## Conditions studied

- DIABETES Mellitus Type 2 Not Well Controlled

## Interventions

- **DRUG:** Liraglutide
- **DRUG:** Sitagliptin

## Key facts

- **NCT ID:** NCT01785043
- **Lead sponsor:** Anna Cruceta
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-03
- **Primary completion:** 2014-03
- **Final completion:** 2014-09
- **Target enrollment:** 13 (ACTUAL)
- **Last updated:** 2015-09-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01785043

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01785043, "Differences in Endothelial Function Amongst Sitagliptin and Liraglutide Users". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT01785043. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*